TI
VYNT

Turner Investments’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Turner Investments’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-632
Closed -$741K – 280
2015
Q3 		$741K Hold
632
– – 0.15% 173
2015
Q2 		$1.11M Sell
632
-34
-5% -$52.9K 0.2% 155
2015
Q1 		$781K Buy
+666
New +$789K 0.14% 185

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Turner Investments's VYNT Position: Q4 2015 in Review

Turner Investments sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2015, closing a stake of 632 shares — an estimated $741K sold.

Turner Investments first reported a position in VYNT in Q1 2015 and held it in 3 quarters. The position peaked at $1.11M in Q2 2015. 40 funds tracked by Wall St. Rank hold VYNT as of Q4 2015.

  • Turner Investments reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Turner Investments sold 632 Vyant Bio, Inc. Common Stock shares in Q4 2015, an estimated $741K.
  • Turner Investments first reported a position in Vyant Bio, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Turner Investments's Vyant Bio, Inc. Common Stock position peaked at $1.11M in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2015.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.